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Abstract 30 
 31 
Atherosclerosis is an inflammatory disease characterized by accumulation of 32 
leukocytes in the arterial intima. Members of the selectin family of adhesion molecules 33 
are important mediators of leukocyte extravasation. However, it is unclear whether L-34 
selectin (L-sel) is involved in the pathogenesis of atherosclerosis. 35 
In the present study, mice deficient in L-selectin (L-sel-/-) animals were crossed 36 
with mice lacking Apolipoprotein E (ApoE-/-). The development of atherosclerosis was 37 
analyzed in double-knockout ApoE / L-sel (ApoE-/- L-sel-/-) mice and the corresponding 38 
ApoE-/- controls fed either a normal or a high cholesterol diet (HCD). After 6 weeks of 39 
HCD, aortic lesions were increased two-fold in ApoE-/- L-sel-/- mice as compared to 40 
ApoE-/- controls (2.46% ± 0.54% vs 1.28% ± 0.24% of total aortic area; p<0.05). 41 
Formation of atherosclerotic lesions was also enhanced in 6-month-old ApoE-/- L-sel-/- 42 
animals fed a normal diet (10.45% ± 2.58% vs 1.87% ± 0.37%; p<0.05). In contrast, 43 
after 12 weeks of HCD, there was no difference in atheroma formation between ApoE-/- 44 
L-sel-/- and ApoE-/- mice. Serum cholesterol levels remained unchanged by L-sel 45 
deletion. Atherosclerotic plaques did not exhibit any differences in cellular composition 46 
assessed by immunohistochemistry for CD68, CD3, CD4, and CD8 in ApoE-/- L-sel-/- as 47 
compared to ApoE-/- mice. Leukocyte rolling on lesions in the aorta was similar in ApoE-/- 48 
L-sel-/- and ApoE-/- animals. ApoE-/- L-sel-/- mice exhibited reduced size and cellularity of 49 
peripheral lymph nodes, increased size of spleen, and increased number of peripheral 50 
lymphocytes as compared to ApoE-/- controls. 51 
These data indicate that L-selectin does not promote atherosclerotic lesion 52 
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formation and suggest that it rather protects from early atherosclerosis.  53 
 54 
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Introduction 56 
 57 
 Endothelial activation and subsequent accumulation of leukocytes is a key event 58 
in early atherosclerosis 1. The selectin family of adhesion molecules mediates initial 59 
rolling and tethering of inflammatory cells at sites of activated endothelium 2-6. The family 60 
consists of the three closely homologous glycoproteins E-selectin (E-sel), P-selectin (P-61 
sel), and L-selectin (L-sel), that all bind glycoproteins and glycolipids bearing sialyl Lewis 62 
X (sLeX) in a calcium-dependent manner 7, 8. Upon stimulation, E-sel is expressed on 63 
endothelial cells, while P-sel is expressed in both endothelial cells and platelets. L-sel, 64 
on the other hand, is constitutively expressed on the majority of leukocytes 6. 65 
L-sel exhibits adhesive as well as signaling functions 9, 10 and is particularly 66 
important for lymphocyte homing to secondary lymphoid organs 5, 11. Indeed, animals 67 
lacking L-sel display an altered size of secondary lymphoid tissues and increased 68 
numbers of peripheral lymphocytes 11-13. Moreover, L-sel deficient mice show reduced 69 
leukocyte rolling along cytokine-stimulated endothelium in vivo. This is well documented 70 
in venules in the microcirculation and primarily depends on a lack of L-sel-mediated 71 
interactions between leukocytes regulating capture of cells from the free flow 14, 15. 72 
Indeed, whether functional L-sel ligand activity is regularly upregulated on inflamed 73 
endothelium is still under debate 16.  74 
Since the selectins are known to regulate leukocyte recruitment in inflammation, 75 
they are interesting candidates to study in the context of atherogenesis. Indeed, mice 76 
deficient in E- and P-sel display attenuated development of atherosclerosis 2, 17. 77 
Moreover, lymphocyte recruitment to the aortic wall during atherosclerosis development 78 
is partially L-sel dependent 18. However, there are no in vivo reports addressing the 79 
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impact of L-sel for the development of atherosclerotic lesions in vivo. In this study, L-80 
selectin deficient (L-sel-/-) mice were crossed with Apolipoprotein E deficient mice (ApoE-81 
/-) to investigate the relevance of L-sel on both early and advanced stages of 82 
atherosclerosis. 83 
84 
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Results 85 
 86 
L-selectin attenuates early, but not advanced atherosclerosis 87 
The development of atherosclerosis was monitored in descending aortas of mice 88 
with or without L-sel. In 12 week old ApoE-/- L-sel-/- animals fed a HCD for 6 weeks, the 89 
percentage of the aorta occupied by atherosclerotic plaques was two fold higher than in 90 
age- and diet-matched ApoE-/- controls (2.46% ± 0.54% vs 1.13% ± 0.19%, respectively; 91 
p<0.05; Fig. 1A). The effect of L-sel deletion was even more pronounced in 6 month old 92 
animals fed a normal diet. Under these conditions, ApoE-/- L-sel-/- mice had 10.45 ± 93 
2.58% of the descending aorta covered by plaques as compared to 1.87 ± 0.37% in 94 
ApoE-/- controls (p<0.05; Fig. 1B). In contrast, the atherosclerotic burden in 18 week old 95 
ApoE-/- L-sel-/- animals fed a HCD for 12 weeks (11.80 ± 1.86%) was similar to that of 96 
ApoE-/- controls (13.89 ± 2.06%; p=n.s.; Fig. 1C). There was no difference in plasma 97 
cholesterol levels between double knockout and control mice in any of the groups 98 
(p=n.s.; Supplemental Table 1). Expression of E-selectin did not differ in  ApoE-/- controls 99 
and ApoE-/- L-sel-/- animals during atherosclerotic lesion formation (p=n.s.; Supplemental 100 
Fig. 1A). P-selectin expression was significantly increased in arteries of ApoE-/- mice 101 
after 6 weeks of HCD compared to ApoE-/- L-Sel-/- mice. (p<0.05; Supplemental Fig. 1B) 102 
Vascular smooth muscle cell accumulation was similar in the two groups (p=n.s.; 103 
Supplemental Fig. 1D). Staining for collagen exhibited a minor increase in plaques from 104 
ApoE-/- L-sel-/- animals as compared to ApoE-/- controls (p<0.05; Supplemental Fig. 1C). 105 
 106 
L-selectin does not influence leukocyte capture and rolling in atherosclerosis. 107 
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Leukocyte capture and rolling were assessed using intravital microscopy. There was no 108 
difference between ApoE-/- and ApoE-/- L-sel-/- animals in primary leukocyte capture 109 
directly to the endothelium from the free flow (5.4 ± 1.3 cells vs 5.5 ± 1.3 cells, 110 
respectively; p=n.s.; Fig. 2A). Secondary capture mediated by interactions between 111 
leukocytes was low in ApoE-/- as well as in ApoE-/- L-sel-/- mice (1.28 ± 0.92 cells vs 0.17 112 
± 0.14 cells, respectively; p=n.s.; Fig. 2B). Correspondingly, there was no difference in 113 
the total number of cells rolling along the aortic endothelium in ApoE-/- controls and 114 
ApoE-/- L-sel-/- mice (p=n.s.; Fig. 2C). Total capture correlated with the number of rolling 115 
cells (Fig. 2D). 116 
 117 
L-selectin does not influence leukocyte accumulation in atherosclerotic plaques. 118 
Immunohistochemistry on the aortic root was performed to monitor the 119 
composition of atherosclerotic plaques following L-sel deletion. Macrophages were 120 
visualized with anti-CD68 antibody, lymphocytes with anti-CD3 antibody, T-helper and 121 
T-cytotoxic cells with anti-CD4 and anti-CD8 antibodies, respectively. L-sel deletion did 122 
not result in an altered CD68 positive area in either early (71.10% ± 1.36% vs 74.44% ± 123 
2.90%; p=n.s.; Fig. 3A) or advanced atherosclerosis (48.20% ± 4.13% vs 39.62% ± 124 
1.99%; p=n.s.; Fig. 3A). Similarly, there was no difference between ApoE-/- and ApoE-/- 125 
L-sel-/- mice in the number of CD3 (p=n.s.; Fig. 3B), CD4 (p=n.s.; Fig. 3C), and CD8 126 
positive cells (p=n.s.; Fig. 3D) after 6 and 12 weeks of HCD. Increased duration of HCD 127 
resulted in a decreased plaque area occupied by macrophages in both ApoE-/- and 128 
ApoE-/- L-sel-/- mice (p<0.05; Fig. 3A). In contrast, no significant difference in T-cell 129 
accumulation was observed after 6 and 12 weeks of HCD (p=n.s.). Cytokine expression 130 
was similar in aortas of ApoE-/- L-sel-/- mice as compared to ApoE-/- controls after 6 and 131 
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12 weeks of HCD (p=ns; Table 1). In contrast, the animals exhibited enhanced cytokine 132 
expression after 12 as compared to 6 weeks of HCD irrespective of the genotype 133 
(p<0.05; Table 1). The majority of circulating cytokines exhibited similar plasma levels in 134 
ApoE-/- and ApoE-/- L-sel-/- mice after 6 weeks of HCD. Interestingly, the level of the 135 
chemotactic cytokine MCP-1 was four fold elevated in plasma of ApoE-/- L-sel-/- mice 136 
(p<0.05; Table 2). 137 
 138 
Increased number of circulating lymphocytes in L-sel-/- mice 139 
ApoE-/- L-sel-/- animals exhibited a 1.4 fold and 1.6 fold increased number of blood 140 
lymphocytes as compared to ApoE-/- controls after 6 and 12 weeks of HCD, respectively 141 
(p<0.05; Fig. 4A). Consistent with this observation, there was an increased number of 142 
CD8+ and CD19+ cells in ApoE-/- L-sel-/- mice irrespectively of the duration of HCD 143 
(p<0.05; Fig. 4B and C). Moreover, there was tendency towards an increased number of 144 
CD4+ cells in ApoE-/- L-sel-/- mice after 6 weeks of HCD (p=0.24), which was significant 145 
after 12 weeks of this diet (p<0.05; Fig. 4D). The increased number of circulating 146 
lymphocytes in ApoE-/- L-sel-/- mice was associated with an increased number of naive T 147 
helper cells (CD4+CD44-; p<0.05; Fig. 4E) after 6 and 12 weeks of HCD. The number of 148 
activated T helper cells (CD4+CD44+) did not differ after 6 weeks, but was lower in 149 
ApoE-/- L-sel-/- as compared to ApoE-/- mice after 12 weeks of HCD (p<0.05; Fig. 4F). No 150 
significant difference in the circulating leukocyte profile was observed after 6 and 12 151 
weeks of HCD in any of the genotypes. 152 
A significant reduction in size (p<0.05; Supplemental Fig. 2A) and cellularity 153 
(p<0.05; Supplemental Fig. 2B) of peripheral lymph nodes was observed in ApoE-/- L-sel-154 
/- as compared to ApoE-/- mice after 6 and 12 weeks of HCD. In contrast, the spleen was 155 
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30% larger in L-sel deficient mice at both time-points (p<0.05; Supplemental Fig. 3A). 156 
The increased spleen size was not associated with an altered cellularity, cell 157 
composition (p=n.s.; Supplemental Fig. 3B and C) or an altered cytokine expression 158 
(p=n.s.; data not shown). 159 
Materials and Methods 160 
 161 
Mice 162 
The development of atherosclerosis in ApoE-/- L-sel-/- mice was studied by two 163 
independent experiments. In the first set, L-sel-/- mice backcrossed to C57Bl/6 164 
background for 9 generations were used. In the other set, L-sel-/- mice were purchased 165 
from Jackson Lab and backcrossed to C57Bl/6 background for 5 generations. L-sel-/- 166 
mice were cross-bred with ApoE-/- mice to generate ApoE-/- L-sel-/- and littermate ApoE-/- 167 
controls. In the first set, 6 week old males were fed a HCD (Clinton-Cybulski diet, 1.25% 168 
cholesterol, Research Diets #D12108) for 6 or 12 weeks. In the other set, male ApoE-/- 169 
L-sel-/- animals and controls were fed a normal diet for 6 months before analysis. All 170 
animal experiments were approved by the appropriate authorities. 171 
 172 
Quantification of atherosclerosis development 173 
Under anesthesia, blood was collected through right ventricular puncture. Mice 174 
were then perfused with ice-cold saline. Aortas were harvested for RNA isolation, en 175 
face, and histological analysis. The thoracic and abdominal part of the aortas were fixed 176 
overnight with 4% paraformaldehyde (PFA), washed 3 times with ice-cold PBS, and 177 
stained for 3 hours with Oil red-O (Sigma #O9755). Quantification of aortic plaque area 178 
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was performed using AnalysisFIVE software manually by an investigator blinded to the 179 
genotypes. 180 
 181 
Plasma triglyceride and cholesterol level 182 
Plasma cholesterol level was determined using Infinity™ Cholesterol (Thermo 183 
Electron Corporation Standard #TR13421) and MC Cal (Abbott #1E65-02), plasma 184 
triglycerides using Infinity™ Triglycerides (Thermo Electron Corporation Standard 185 
#TR22421) and MC Cal (Abbott #1E65-02). The distribution of lipids within the plasma 186 
lipoprotein fractions was assessed by fast-performance liquid chromatography (FPLC) 187 
gel filtration using a Superose 6 HR 10/30 column (Pharmacia). 188 
 189 
Immunohistochemistry 190 
Aortic roots were harvested, mounted in O.C.T. compound (Tissue-Tek #62550-191 
01) and frozen at -20°C. 8 μm-thick slices were fixed with 4% PFA and stained with anti-192 
mouse CD3, CD4 CD8, or CD68 antibodies (Serotec), followed by incubation with 193 
alkaline phosphatase–conjugated secondary antibody (Jackson ImmunoResearch). 194 
Aortic arches were fixed with 4% formalin and embedded in paraffin. Sections were 195 
stained with anti-mouse α-SMA (clone 1A4, SIGMA), E-selectin (abcam), and P-selectin 196 
(LSBio). Percentages of stained area were quantified with AnalySIS-FIVE program.  197 
 198 
Intravital microscopy 199 
18 week old male mice fed with a HCD for 12 weeks were anesthetized with 200 
isofluran. The aorta was prepared as described previously 19. Briefly, the abdomen was 201 
opened by a midline incision and the intestines were retracted. The peritoneum was 202 
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then dissected to expose the abdominal aorta. The exposed tissue was superfused with 203 
a thermostated (37°C) bicarbonate-buffered saline solution. Microscopic observations 204 
were made using an intravital microscope (Leitz Biomed) with a water immersion 205 
objective (Leitz SW 25×). Epi-illumination fluorescence microscopy (Leitz Ploem-o-pac, 206 
filter block M2 illuminated by a cooled infrared filtered lamp (Osram HBO 200W/4)) was 207 
started 2 minutes after labeling of circulating leukocytes with an intravenous injection of 208 
rhodamine 6G (0.3 mg/ml, 0.67 mg/kg). Images were televised and recorded on 209 
videotape using a VNC-703 video camera. Leukocyte rolling flux was determined as the 210 
average number of leukocytes rolling within a 10000 μm2 area during 30 seconds within 211 
a total observation time of at least 180 seconds. Leukocyte capture was determined as 212 
the number of leukocytes that initiated rolling within a 10000 μm2 area during 30 213 
seconds20. Leukocyte capture in contact with or 50 μm downstream of rolling or 214 
adherent leukocytes were regarded as secondary, all other capture was regarded as 215 
primary. 216 
 217 
FACS 218 
Blood cells were stained with fluorescently labeled anti-mouse CD4 (PE-219 
conjugated, clone RM4-5), CD8 (PE-Cy7-conjugated, clone H35-17.2), CD19 (PE-Cy7-220 
conjugated, clone 1D3), or CD44 (APC-conjugated, clone IM7) antibodies (Pharmingen) 221 
for 30 minutes at 4°C. Erythrocytes were lyzed following staining using commercially 222 
available lysis buffer (BD #555899). Data were collected using DIVAII (BD), and FACS 223 
analysis was performed using FlowJo software. 224 
 225 
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Statistical analysis 226 
The results were expressed as mean ± S.E.M. Comparison of means was carried 227 
out by Student’s t-test or ANOVA in case of multiple comparisons. For each experiment, 228 
P<0.05 was accepted as statistically significant. 229 
230 
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Discussion 231 
 232 
 Accumulation of leukocytes in the arterial wall is an important pathogenic event in 233 
atherogenesis. It is well documented that the selectin family of adhesion molecules 234 
mediates initial attachment of leukocytes to activated endothelium, representing the first 235 
step of leukocyte emigration into sites of inflammation 2, 6. Correspondingly, L-selectin 236 
may play a role in the migration of leukocytes to atherosclerotic lesions and data have 237 
been presented supporting that lymphocyte recruitment during atherosclerosis 238 
development is partially L-sel dependent 18. Thus, we hypothesized that deletion of L-sel 239 
might attenuate the development of atherosclerosis due to inhibition of leukocyte rolling 240 
and capture. To test this hypothesis, we compared atherogenesis in ApoE-/- L-sel-/- mice 241 
with that of ApoE-/- controls21. Interestingly, the data show that L-sel does not promote 242 
atherosclerotic lesion formation in ApoE-/- mice. On the contrary, genetic deficiency in L-243 
selectin resulted in a significant increase in lesion formation, at least during early stages 244 
of the disease. Indeed, after 6 month of normal diet, atherosclerosis was relatively 245 
advanced in the absence of L-Selectin, while plaque burden was still low in the ApoE-/- 246 
control group and comparable to the ApoE-/- control animals after 6 weeks of HCD. 247 
Thus, both feeding protocols induce an early stage of the disease; however, the 248 
absence of L-sel results in a strong increase of atherosclerosis. In line with this, there 249 
was no decrease in leukocyte rolling between ApoE-/- L-sel-/- and ApoE-/- control mice in 250 
the atherosclerotic aorta. These observations indicate that other members of the selectin 251 
family are sufficient to maintain leukocyte-endothelium interactions under conditions of 252 
L-sel deletion 17, 22, 23. In line with this interpretation, expression of E-selectin and P-253 
selectin were not upregulated in the absence of L-Selectin during atherosclerotic lesion 254 
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formation. Previous data reveal that the effect of combined deficiency of P- and E-255 
selectin has an effect on rolling and recruitment in inflammation which is much stronger 256 
than that seen in mice deficient in L-sel 22, 23. Blockage of P-selectin also virtually 257 
abolishes interactions between leukocytes and endothelium in the atherosclerotic aorta 258 
and inhibition of E-selectin stabilizes leukocyte rolling under these conditions2 supporting 259 
that E- and P-selectin are key mediators of initial leukocyte attachment in arteries. 260 
Combined deficiency in E-sel and P-sel also strongly reduces the formation of 261 
atherosclerotic lesions 17. In contrast, as previously indicated 14, L-selectin-dependent 262 
secondary capture does not increase rolling on atherosclerotic endothelium. 263 
Nonetheless, L-selectin increases rolling in venules in the microcirculation 11, 14, 24, which 264 
has been shown to be dependent mainly on interactions between leukocytes. Ligands 265 
for L-selectin are only expressed by endothelium in secondary lymphoid tissues and, 266 
under certain circumstances, also by chronically inflamed systemic endothelium 18, 25. 267 
Interestingly, data from a previous study suggested that L-sel dependent accumulation 268 
of lymphocytes in arteries occurs almost exclusively from the adventitial side of the 269 
vessel suggesting that L-sel influences recruitment from the vasa vasorum 18. This 270 
apparent role of L-sel could be mediated by both direct interactions between leukocytes 271 
and endothelium as well as secondary capture interactions. Thus, it is possible that L-272 
selectin influences rolling and recruitment in other parts of the vascular wall than in the 273 
arterial lumen. A strong argument against this interpretation is that plaques from ApoE-/- 274 
L-sel-/- mice exhibited similar numbers of macrophages and T cells as compared to 275 
lesions from ApoE-/- controls. Ideally, the cellular composition of the plaque should be 276 
examined in the descending aorta, i.e. at that site of the aorta in which significant 277 
differences in plaque size were noted. As the atherosclerotic alterations in the 278 
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descending aorta are focal, it is virtually impossible to cut the descending aorta at the 279 
same site and find a plaque of similar size to assess and compare its composition. For 280 
this reason, cellular plaque composition was studied in the aortic sinuses, i.e. at a site 281 
where plaques of similar size could consistently be detected. It has been observed that 282 
even if plaque size is similar at the level of the aortic root, differences in plaque 283 
composition can be detected26.  284 
No difference in cytokine expression in atherosclerotic vessel walls from ApoE-/- 285 
L-sel-/- and ApoE-/- mice was detected indicating a similar extent of local inflammation 286 
without or with L-sel. The enhanced aortic cytokine levels in animals treated with HCD 287 
for 12 weeks as compared to those treated for 6 weeks is consistent with a more 288 
advanced stage of atherosclerosis in these mice and did not differ between strains. 289 
Hence, alterations in local inflammation do not seem to account for the atheroprotective 290 
actions of L-selectin. In line with these observations, plasma cytokine levels were similar 291 
in ApoE-/- L-sel-/- and ApoE-/- mice. In plasma of ApoE-/- L-sel-/- mice fed a HCD for 6 292 
weeks the levels of the chemotactic cytokine MCP-1 were elevated  compared to ApoE-/- 293 
mice, which most likely reflects the increased plaque burden in these animals. 294 
Atherosclerosis does not only affect the wall of blood vessels, but also provokes 295 
changes at the systemic level 27, 28. Deletion of L-sel resulted in abnormal systemic 296 
leukocyte distribution, which could potentially affect atherosclerosis development 29. 297 
Both size and cellularity of peripheral lymph nodes were decreased in ApoE-/- L-sel-/- 298 
mice as compared to ApoE-/- controls, which is consistent with the observation that 299 
migration of naive lymphocytes into peripheral lymph nodes is impaired in L-sel deficient 300 
mice 11, 13. Likely due to compensation for this impaired migration into tissues, L-sel 301 
deficiency results in increased numbers of circulating lymphocytes. Hence, it is possible 302 
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that the enhanced atherosclerosis in ApoE-/- L-sel-/- mice is driven by more abundant 303 
circulating proatherogenic cells, in particular because migration of these cells into 304 
lesions appears not to be impaired by lack of L-selectin 2, 30 .  305 
 In conclusion, this study demonstrates that absence of L-sel does not inhibit 306 
atherosclerosis but rather augments the early stages of atherogenesis. This effect is not 307 
associated with reduced leukocyte rolling or accumulation nor with altered cytokine 308 
production in atherosclerotic plaques. 309 
310 
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Figures legends 322 
 323 
Figure 1 324 
L-sel modulates atherosclerosis development 325 
Representative images of aortas stained with Oil-Red-O (ORO). Atherosclerotic lesion 326 
area is expressed as percentage of total aortic area. Compared to ApoE-/- controls, there 327 
is an increased atherosclerotic burden in A) 12 week old ApoE-/- L-sel-/- animals after 6 328 
weeks of HCD (n=11-15; *p<0.05); and B) 6 month old ApoE-/- L-sel-/- animals after 6 329 
months of a normal diet (n=5-9; *p<0.05), but not C) 18 week old ApoE-/- L-sel-/- animals 330 
after 12 weeks of HCD (n=10-15; p=n.s.). 331 
 332 
Figure 2 333 
L-sel does not affect leukocyte capture and rolling in atherosclerosis. 334 
There was no difference between ApoE-/- and ApoE-/- L-sel-/- animals in either A) primary 335 
or B) secondary leukocyte capture (n=7; p=n.s.). C) Leukocyte rolling in atherosclerotic 336 
aorta was not affected by the presence or absence of L-sel (n=7; p=ns). D) Total 337 
leukocyte capture was proportional to leukocyte rolling flux (R=0.8).  338 
 339 
Figure 3 340 
L-sel does not affect leucocyte accumulation in atherosclerotic plaques 341 
Immunohistochemical analysis of A) macrophages (CD68+), B) T-lymphocytes (CD3+), 342 
C) T helper cells (CD4+), and D) T-cytotoxic cells (CD8+) after 6 and 12 weeks of HCD 343 
(n=5-13; p=n.s.). 344 
 345 
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Figure 4  346 
L-sel decreases the number of circulating lymphocytes 347 
ApoE-/- L-sel-/- animals exhibit increased number of A) total blood lymphocytes (n=5-8; 348 
*p<0.05), B) T-cytotoxic cells (CD8+; n=6-7; **p<0.01, #p<0.05), C) B lymphocytes 349 
(CD19+; n=5-7; *p<0.05, #p<0.05), D) total T-helper cells (CD4+; n=6-7; #p<0.0), E) naive 350 
T-helper cells (CD4+CD44-; n=5-7; *p<0.05; ##p<0.0001) after 6 and 12 weeks of HCD, 351 
respectively. F) The number of activated T-cells (CD4+CD44+) remained unchanged 352 
after 6 weeks of HCD (n=5-7; p=n.s.) and decreased after 12 weeks of HCD (n=5-7; 353 
*p<0.05) as compared to control. 354 
 355 
Supplemental Figure 1 356 
Histochemical and immunohistochemical stainings of aortic arches from mice fed a HCD 357 
for 6 weeks: A) Similar expression of E-selectin in ApoE-/- and ApoE-/- L-sel-/- mice. B) 358 
Increased expression of P-selectin in ApoE-/- compared to ApoE-/- L-sel-/- mice (p<0.05) 359 
C) Collagen area is increased in ApoE-/- L-Sel-/- mice compared to ApoE-/- mice (p<0.01) 360 
D) Smooth muscle cell area is similar in ApoE-/- and ApoE-/- L-sel-/- mice. 361 
 362 
Supplemental Figure 2 363 
Decreased A) size (n=5-6; **p<0.01; ##p<0.01) and B) cellularity (n=5-6; *p<0.05; 364 
#p<0.05) of peripheral lymph nodes (LN) in mice lacking L-sel after 6 and 12 weeks of 365 
HCD. 366 
 367 
Supplemental Figure 3 368 
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A) Spleen size is increased upon L-sel deletion (n=6; **p<0.01; #p<0.05). B) Spleen 369 
cellularity is not affected by L-sel deletion (n=5-6; *p=n.s.) after 6 and 12 weeks of HCD. 370 
C) Increased size but unchanged cell composition (table; % of leukocytes ± SEM) of 371 
spleens from animals after 6 month of normal diet. 372 
 373 
374 
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Tables 375 
 376 
Table 1  377 
mRNA expression (normalized to S12 expression) of different cytokines in 378 
atherosclerotic plaques is not affected by L-sel after 6 and 12 weeks of HCD. 379 
 380 
Table 2 381 
Plasma MCP-1 is elevated in ApoE-/- L-sel-/- mice compared to ApoE-/- mice after 6 382 
weeks of HCD, while the other plasma cytokines are not affected. 383 
 384 
Supplemental Table 1 385 
Plasma cholesterol and triglyceride levels (n=5-12; p=n.s.) after normal diet or 6 and 12 386 
weeks of HCD. 387 
388 
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Figure 4
6 weeks 12 weeks
expression level ApoE-/- ApoE-/- L-sel-/- ApoE-/- ApoE-/- L-sel-/-
MCP-1 (x10-2) 2.02 ± 0.58 2.59 ± 0.37 5.22 ± 1.47 5.95 ± 1.20
TNFα (x10-3) 1.40 ± 0.39 1.40± 0.15 3.90 ± 1.30 4.2 ± 1.01
INFγ (x10-4) 4.51 ± 1.8 3.88 ± 0.7 18.71 ± 8.00 25.45 ± 10.30
Mip-1 (x10-2) 3.44 ± 0.59 2.84 ± 0.36 5.88 ± 1.88 3.14 ± 0.65
IL-4 (x10-4) 4.43 ± 1.20 3.51 ± 0.4 11.01 ± 3.7 10.11 ± 2.7
IL-6 (x10-3) 1.11 ± 0.22 1.34 ± 0.25 2.32 ± 0.64 2.22 ± 0.59
IL-10 (x10-4) 2.22 ± 1.00 2.79 ± 0.40 6.51 ± 1.60 4.79 ± 1.3
Table 1
plasma concentration 
(pg/ml) ± st.dev. ApoE-/- ApoE-/- L-Sel-/- p
GM-CSF 10.8 ± 3.3 11.6 ±6.8 0.805
IFN-γ 63.5 ± 35.7 43.2 ± 16.0 0.274
IL-1β 20.9 ± 11.1 15.1 ± 4.2 0.307
IL-2 13.2 ± 4.3 12.0 ± 5.5 0.694
IL-4 19.3 ± 6.2 16.4 ± 2.1 0.349
IL-5 192.7 ± 71.0 125.6 ± 38.8 0.093
IL-6 37.9 ± 18.0 61.6 ± 20.2 0.070
IL-10 83.5 ± 11.6 80.1 ± 13.7 0.664
IL-12 47.2 ± 8.9 46.3 ± 4.7 0.844
IL-17 132.0 ± 49.1 89.2 ± 10.1 0.090
MCP-1 86.5 ± 79.1 332.7 ± 230.5 0.035
RANTES 16.9 ± 11.1 8.9 ± 5.9 0.183
VEGF 43.2 ± 13.5 65.0 ± 30.0 0.141
Table 2
Supplement 1 
Supplemental Figure 1 2 
3 
 4 
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 II
Histochemical and immunohistochemical stainings of aortic arches from mice fed a HCD 5 
for 6 weeks: A) Similar expression of E-selectin in ApoE-/- and ApoE-/- L-sel-/- mice. B) 6 
Increased expression of P-selectin in ApoE-/- compared to ApoE-/- L-sel-/- mice (p<0.05) 7 
C) Collagen area is increased in ApoE-/- L-Sel-/- mice compared to ApoE-/- mice (p<0.01) 8 
D) Smooth muscle cell area is similar in ApoE-/- and ApoE-/- L-sel-/- mice. 9 
 10 
Supplemental Figure 2 11 
 12 
Decreased A) size (n=5-6; **p<0.01; ##p<0.01) and B) cellularity (n=5-6; *p<0.05; 13 
#p<0.05) of peripheral lymph nodes (LN) in mice lacking L-sel after 6 and 12 weeks of 14 
HCD. 15 
 16 
17 
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 III
Supplemental Figure 3 18 
A) Spleen size is increased upon L-sel deletion (n=6; **p<0.01; #p<0.05). B) Spleen 19 
cellularity is not affected by L-sel deletion (n=5-6; *p=n.s.) after 6 and 12 weeks of HCD. 20 
C) Increased size but unchanged cell composition (table; % of leukocytes ± SEM) of 21 
spleens from animals after 6 month of normal diet. 22 
23 
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 IV
Supplemental Tables 24 
 25 
Supplemental Table 1 26 
 27 
Plasma cholesterol and triglyceride levels (n=5-12; p=n.s.) after normal diet or 6 and 12 28 
weeks of HCD. 29 
 30 
